The new guidelines are designed to establish standard molecular marker testing and targeted therapies for patients with primary or metastatic colorectal carcinoma.
The guidelines are open to public comment through April 22.
Click here to read the full set of guidelines.
More articles on gastroenterology:
Dr. Christopher Meyer named CEO of Holzer Health System
Squaring off in GI: Employment vs. private practice
5 most read GI articles – March 30 to April 3
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
